Resumo
Definição
História e exame físico
Principais fatores diagnósticos
- abdominal bloating
- fatigue
- breast tenderness
- headaches
- depressed mood, irritability, and internal tension
- labile mood
- adverse effect on life
Outros fatores diagnósticos
- increased appetite
- forgetfulness and difficulty concentrating
- other subjective symptoms
- insomnia or hypersomnia
- gastrointestinal upset
- heart palpitations
- hot flashes
Fatores de risco
- postpubescent and premenopausal women
- family history
- mood disorders
- cigarette smoking
- white women
- sexual abuse and/or trauma
- alcohol consumption
Investigações diagnósticas
Primeiras investigações a serem solicitadas
- prospective symptom diary
Investigações a serem consideradas
- thyroid function tests
- follicle-stimulating hormone levels
- depression screening
- CBC
Algoritmo de tratamento
mild PMS
moderate to severe PMS or PMDD
Colaboradores
Autores
Nancy A. Phillips, MD
Associate Professor
Department of Obstetrics, Gynecology and Reproductive Sciences
Rutgers Robert Wood Johnson Medical School
New Brunswick
NJ
Declarações
NAP has been reimbursed by Synexis Pharma, manufacturer of Ibrexafungerp, for attending advisory boards. NAP is on the North American Board of the North American chapter of the ISSVD (International Society for the Study of Vulvovaginal Disease). NAP has received grants from Syneos for a study on Myfembree.
Gloria Bachmann, MD
Professor
Department of Obstetrics, Gynecology and Reproductive Sciences
Rutgers Robert Wood Johnson Medical School
New Brunswick
NJ
Declarações
GB declares that she has no competing interests.
Agradecimentos
Dr Nancy A. Phillips and Dr Gloria Bachmann would like to gratefully acknowledge Professor Margaret Rees and Dr Desiree Lie, the previous contributors to this topic.
Declarações
MR and DL declare that they have no competing interests.
Revisores
Julianne Toohey, MD
Obstetrician-Gynecologist
Department of Obstetrics and Gynecology
University of California Irvine Medical Center
Orange
CA
Declarações
JT declares that she has no competing interests.
Carol Henshaw, MB ChB, MD
Consultant in Perinatal Mental Health
Liverpool Women's NHS Foundation Trust
Liverpool
UK
Declarações
CH declares that she has no competing interests.
Peer reviewer acknowledgements
BMJ Best Practice topics are updated on a rolling basis in line with developments in evidence and guidance. The peer reviewers listed here have reviewed the content at least once during the history of the topic.
Disclosures
Peer reviewer affiliations and disclosures pertain to the time of the review.
Referências
Principais artigos
American College of Obstetricians and Gynecologists. ACOG clinical practice guideline no. 7: management of premenstrual disorders. Dec 2023 [internet publication].Texto completo
Ismaili E, Walsh S, O'Brien PMS, et al; Consensus Group of the International Society for Premenstrual Disorders. Fourth consensus of the International Society for Premenstrual Disorders (ISPMD): auditable standards for diagnosis and management of premenstrual disorder. Arch Womens Ment Health. 2016 Dec;19(6):953-8. Resumo
Green LJ, O’Brien PMS, Panay N, et al; Royal College of Obstetricians and Gynaecologists. Management of premenstrual syndrome: green-top guideline no. 48. BJOG. 2017 Feb;124(3):e73-105.Texto completo Resumo
World Health Organization. International classification of diseases 11th revision. Jan 2022 [internet publication].Texto completo
Artigos de referência
Uma lista completa das fontes referenciadas neste tópico está disponível para os usuários com acesso total ao BMJ Best Practice.
Diagnósticos diferenciais
- Depression
- Thyroid disease
- Generalized anxiety disorder
Mais Diagnósticos diferenciaisDiretrizes
- Management of premenstrual disorders
- Management of premenstrual syndrome
Mais DiretrizesFolhetos informativos para os pacientes
Premenstrual syndrome
Mais Folhetos informativos para os pacientesConectar-se ou assinar para acessar todo o BMJ Best Practice
O uso deste conteúdo está sujeito ao nosso aviso legal